| D010049 |
Ovarian Diseases |
Pathological processes of the OVARY. |
Disease, Ovarian,Diseases, Ovarian,Ovarian Disease |
|
| D003338 |
Corpus Luteum |
The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. |
Corpora Lutea,Lutea, Corpora |
|
| D005260 |
Female |
|
Females |
|
| D006470 |
Hemorrhage |
Bleeding or escape of blood from a vessel. |
Bleeding,Hemorrhages |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000328 |
Adult |
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. |
Adults |
|
| D000925 |
Anticoagulants |
Agents that prevent BLOOD CLOTTING. |
Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect |
|
| D012422 |
Rupture, Spontaneous |
Tear or break of an organ, vessel or other soft part of the body, occurring in the absence of external force. |
Ruptures, Spontaneous,Spontaneous Rupture,Spontaneous Ruptures |
|
| D014859 |
Warfarin |
An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. |
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin |
|